US 8217056
Triazolothiadiazole inhibitor of c-Met protein kinase
granted A61PA61P11/00A61P35/00
Quick answer
US patent 8217056 (Triazolothiadiazole inhibitor of c-Met protein kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P11/00, A61P35/00, A61P35/04, A61P43/00